Literature DB >> 21965653

E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes.

Yael David1, Nicola Ternette2, Mariola J Edelmann2, Tamar Ziv3, Batya Gayer1, Rotem Sertchook4, Yakir Dadon1, Benedikt M Kessler2, Ami Navon5.   

Abstract

Ubiquitin-conjugating enzymes (E2s) have a dominant role in determining which of the seven lysine residues of ubiquitin is used for polyubiquitination. Here we show that tethering of a substrate to an E2 enzyme in the absence of an E3 ubiquitin ligase is sufficient to promote its ubiquitination, whereas the type of the ubiquitin conjugates and the identity of the target lysine on the substrate are promiscuous. In contrast, when an E3 enzyme is introduced, a clear decision between mono- and polyubiquitination is made, and the conjugation type as well as the identity of the target lysine residue on the substrate becomes highly specific. These features of the E3 can be further regulated by auxiliary factors as exemplified by MDMX (Murine Double Minute X). In fact, we show that this interactor reconfigures MDM2-dependent ubiquitination of p53. Based on several model systems, we propose that although interaction with an E2 is sufficient to promote substrate ubiquitination the E3 molds the reaction into a specific, physiologically relevant protein modification.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965653      PMCID: PMC3243545          DOI: 10.1074/jbc.M111.234559

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.

Authors:  D A Sharp; S A Kratowicz; M J Sank; D L George
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

2.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  Isolation and identification of the human homolog of a new p53-binding protein, Mdmx.

Authors:  A Shvarts; M Bazuine; P Dekker; Y F Ramos; W T Steegenga; G Merckx; R C van Ham; W van der Houven van Oordt; A J van der Eb; A G Jochemsen
Journal:  Genomics       Date:  1997-07-01       Impact factor: 5.736

4.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

5.  MDMX: a novel p53-binding protein with some functional properties of MDM2.

Authors:  A Shvarts; W T Steegenga; N Riteco; T van Laar; P Dekker; M Bazuine; R C van Ham; W van der Houven van Oordt; G Hateboer; A J van der Eb; A G Jochemsen
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair.

Authors:  R M Hofmann; C M Pickart
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

7.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

8.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

9.  Ubiquitin-mediated degradation of histone H3 does not require the substrate-binding ubiquitin protein ligase, E3, or attachment of polyubiquitin chains.

Authors:  A Haas; P M Reback; G Pratt; M Rechsteiner
Journal:  J Biol Chem       Date:  1990-12-15       Impact factor: 5.157

10.  A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein.

Authors:  V Chau; J W Tobias; A Bachmair; D Marriott; D J Ecker; D K Gonda; A Varshavsky
Journal:  Science       Date:  1989-03-24       Impact factor: 47.728

View more
  31 in total

Review 1.  Mechanisms for countering oxidative stress and damage in retinal pigment epithelium.

Authors:  Scott M Plafker; Gary B O'Mealey; Luke I Szweda
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

2.  Isg15 controls p53 stability and functions.

Authors:  Yi-Fu Huang; Sheena Wee; Jayantha Gunaratne; David P Lane; Dmitry V Bulavin
Journal:  Cell Cycle       Date:  2014-05-20       Impact factor: 4.534

3.  The ability of TRIM3 to induce growth arrest depends on RING-dependent E3 ligase activity.

Authors:  Radhika Raheja; Yuhui Liu; Ellen Hukkelhoven; Nancy Yeh; Andrew Koff
Journal:  Biochem J       Date:  2014-03-15       Impact factor: 3.857

Review 4.  Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

Authors:  Tiffany Devine; Mu-Shui Dai
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors.

Authors:  M New; H Olzscha; G Liu; O Khan; L Stimson; J McGouran; D Kerr; A Coutts; B Kessler; M Middleton; N B La Thangue
Journal:  Cell Death Differ       Date:  2013-05-24       Impact factor: 15.828

Review 6.  Measuring activity in the ubiquitin-proteasome system: from large scale discoveries to single cells analysis.

Authors:  Adam T Melvin; Gregery S Woss; Jessica H Park; Marcey L Waters; Nancy L Allbritton
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

7.  Dissecting the pathways that destabilize mutant p53: the proteasome or autophagy?

Authors:  Sujata Choudhury; Vamsi K Kolukula; Anju Preet; Chris Albanese; Maria Laura Avantaggiati
Journal:  Cell Cycle       Date:  2013-03-06       Impact factor: 4.534

8.  The E3 ubiquitin ligase Pib1 regulates effective gluconeogenic shutdown upon glucose availability.

Authors:  Vineeth Vengayil; Zeenat Rashida; Sunil Laxman
Journal:  J Biol Chem       Date:  2019-10-11       Impact factor: 5.157

9.  Degradation of selenoprotein S and selenoprotein K through PPARγ-mediated ubiquitination is required for adipocyte differentiation.

Authors:  Jea Hwang Lee; Jun Ki Jang; Kwan Young Ko; Yunjung Jin; Minju Ham; Hyunwoo Kang; Ick Young Kim
Journal:  Cell Death Differ       Date:  2018-08-06       Impact factor: 15.828

10.  Diggin' on u(biquitin): a novel method for the identification of physiological E3 ubiquitin ligase substrates.

Authors:  Carrie E Rubel; Jonathan C Schisler; Eric D Hamlett; Robert M DeKroon; Mathias Gautel; Oscar Alzate; Cam Patterson
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.